DALLAS, June 8, 2017 /PRNewswire/ - Alternate Health Corp ("Alternate Health" or the "Company") (CSE:AHG) (OTC:AHGIF),an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices, commenced
Since becoming a public company in January 2017, the Company has engaged third party providers (Finsbury, CFN Media, Stockhouse, Investing Media Solutions, Money Channel, Planet Microcap, See Thru Equity and Canada Newswire) to provide public relations, marketing or other related services. Recently, the Company engaged an advertising and media firm to assist with a managed public awareness campaign, through paid third party agents and newsletter distributors.
On June 6, 2017, the Company received notice from the OTC Markets about promotional activities in relation to the Company and its common shares, including certain promotional newsletter emails. The Company had not reviewed or seen these newsletters prior to publication and was not aware of the promotional nature of the materials. Neither the Company nor its officers, directors, and to the best of its knowledge, its controlling shareholders have directly, or indirectly, authorized or been involved in any way with the creation of the promotional materials.
The Company has determined that certain statements included in these newsletters related to the Company and its business may be misleading and/or incomplete and readers should not place undue reliance on these newsletters. The Company encourages investors to review its filings and disclosures made with Canadian securities regulators, available at www.sedar.com and as posted on the filings and disclosure page for AHGIF on the OTC Markets website at www.otcmarkets.com.
Since becoming a public company on January 19, 2017, the Company has completed two private placements of common shares. The first private placement of 2,914,354 common shares, priced at CAD$1.50, closed on January 20, 2017, with a statutory hold period that expired on May 21, 2017. The second private placement of 2,328,940 common shares, priced at CAD$3.25, closed on March 6, 2017, with a statutory hold period that expires on July 7, 2017.
Since becoming a public company, daily trading volumes have been minimal with volume increasing that the Company attributes to continued advancement of Alternate Health's business, recent earnings news releases and the expiry of the statutory hold period on May 21, 2017 of 2,914,354 common shares.
As disclosed in the Company's news release of April 17, 2017, Alternate Health granted 580,000 incentive stock options to directors, officers and consultants of the Company at an exercise price of CAD$4.00 per common share, and granted an aggregate of 867,544 warrants to officers of the Company at an exercise price of CAD$3.91 per common share. An officer of the Company acquired 13,333 common shares on May 23, 2017, in a private purchase and sale transaction. In accordance with the rules and policies of the CSE, the Company has not issued convertible securities (warrants or options) below current market price.
About Alternate Health Corp.Alternate Health Corp. (CSE:AHG, OTCQB:AHGIF) is an international medical cannabis company that uses best in class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in modern medical practices. The company is strategically positioned in all facets of the medical cannabis value chain through the innovative integration of proprietary technology and know-how, acquisitions and partnerships, deep direct knowledge of and experience with improving patient outcomes, and management expertise. Alternate Health is well positioned to reinvest internal operating cash flow in its platform over the long term, creating an attractive investment profile for its shareholders. The company is headquartered in the Dallas Metroplex with operations in Los Angeles, San Antonio and Toronto.
For more information about Alternate Health Corp., visit www.alternatehealth.ca
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, which are not historical in nature are intended to be, and are hereby identified as "forward-looking statements". Forward-looking statements may be identified by words including "anticipates", "believes", "intends", "estimates", "expects" and similar expressions. The Company cautions readers that forward-looking statements, including without limitation those relating to the Company's future operations, business prospects and financing plans, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward looking statements.
SOURCE Alternate Health Corp.
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All